In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>

<i>Acinetobacter baumannii</i> is currently classified as one of six pathogens that contribute to increased patient mortality. Thus, exploratory studies navigating alternative treatment strategies are of supreme interest. Herein, we completed minimum inhibitory concentration (MIC) testing, and time-...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Jacinda C. Abdul-Mutakabbir, Juwon Yim, Logan Nguyen, Philip T. Maassen, Kyle Stamper, Zain Shiekh, Razieh Kebriaei, Ryan K. Shields, Mariana Castanheira, Keith S. Kaye, Michael J. Rybak
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2021-07-01
Saila:	Antibiotics
Gaiak:	<i>Acinetobacter baumannii</i> multidrug-resistant carbapenem-resistant colistin-resistant
Sarrera elektronikoa:	https://www.mdpi.com/2079-6382/10/7/880
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!